Pharma Commercialisation Services
CG Results Healthcare has a long and distinguished history supporting transactions for companies that service the commercialisation of pharmaceuticals and devices by pharma, generic and medical device companies.
CG Results executed its first transaction in this sector in 1998 with the sale of Adelphi to Omnicom Group. More recently we’ve worked on the sale of iSafety Systems, an Indian pharmacovigilance company which we sold to ProPharma Group, a US company providing drug regulatory services to pharma, generic and biotech companies, in 2021. Between these dates CG Results Healthcare has been involved in many transactions with a wide range of companies (founder owned or PE-backed) that provide expert services including digital transformation, consulting, analytics, market access, salesforce training, PR and media, to the healthcare industry.